Maximilian Siebert

12PUBLICATIONS
55CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)European Union lawResearch, science and technology policyScience, technology and engineering curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Completion and outcomes of postmarketing requirements and commitments issued by the US Food and Drug Administration for new drugs, 2016-24: cross sectional evaluation of postmarketing studies.

|Jul 26, 2026
Navigating the Prescription Drug Information System.

|Jul 21, 2026
Assessment of United States Food and Drug Administration Approval of Cell and Gene Therapies.

|Apr 07, 2026
Evidence supporting European Medicines Agency drug approvals (2020-2023): A cross-sectional study of trial design and outcomes.

Maximilian Siebert, Laura Caquelin, Florian Naudet

|Dec 17, 2025
Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study.

Rylee McGonigle, Huseyin Naci, Maximilian Siebert

|Nov 06, 2023
Towards transparency: adoption of WHO best practices in clinical trial registration and reporting among top medical research funders in the USA.

Elise Gamertsfelder, Netzahualpilli Delgado Figueroa, Sarai Keestra

Pageof 2

Frequent Collaborators

5 joint publications

Florian Naudet

4 joint publications

David Moher

3 joint publications

Florence T Bourgeois

3 joint publications

Huseyin Naci